Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma

PURPOSE: The goals of our study were (a) to validate a molecular expression signature (cell cycle progression [CCP] score and molecular prognostic score [mPS; combination of CCP and pathological stage {IA or IB}]) that identifies stage I lung adenocarcinoma (ADC) patients with a higher risk of cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Eguchi, Takashi, Kadota, Kyuichi, Chaft, Jamie, Evans, Brent, Kidd, John, Tan, Kay See, Dycoco, Joe, Kolquist, Kathryn, Davis, Thaylon, Hamilton, Stephanie A., Yager, Kraig, Jones, Joshua T., Travis, William D., Jones, David R., Hartman, Anne-Renee, Adusumilli, Prasad S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085225/
https://www.ncbi.nlm.nih.gov/pubmed/27153551
http://dx.doi.org/10.18632/oncotarget.9129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085225/
https://www.ncbi.nlm.nih.gov/pubmed/27153551
http://dx.doi.org/10.18632/oncotarget.9129

Ejemplares similares